In this report, our objective was to optimize a method for the extraction of cannabinoids from a clone of Cannabis sativa L. #138 resulting from an agronomic test (LaFleur, Angers, FR) ...
Lire La Suite >

LaFleur publishes its book "Le Cannabis Médical" which proposes an enlightenment on the uses of medical cannabis as a central therapeutic and associates an adapted authorization regime ...
Lire La Suite >

DelleD and the Agrocampus Ouest Foundation have joined forces to create an "AgroHealth" corporate chair.In order to elaborate an efficient agronomic engineering, under controlled conditions, aiming at optimizing and standardizing the architectural development of the cannabis plant.The "AgroHealth Innovation" chair is part of a context of evolution in agronomy practices ...
Lire La Suite >

At a time when France needs to support the strategic health sector, DelleD announces that it has obtained €500k in funding for its research project on cancer treatment. LAFLEUR: A LABORATORY FOR PLANT-BASED HEALTH INNOVATION Nearly 400,000 people are affected by cancer in France and the number of deaths is ...
Lire La Suite >

Call for tenders sprayers On 26 March, Health Minister Olivier Véran was in Clermont-Ferrand to announce the launch of the therapeutic cannabis experiment. Medical cannabis will be made available to patients for two years in two forms: oils administered orally and flowering tops (dried flowers) to be vaporised for inhalation ...
Lire La Suite >

Cannabinoids act on the body through the endocannabinoid system.  The phytocannabinoids in the cannabis plant work in a similar way to our naturally occurring endocannabinoids. The endocannabinoid system The human body has specific receptors on the surface of many cell types for cannabinoids. Our body also produces several endogenous cannabinoids ...
Lire La Suite >

The Agence Nationale de Sécurité du Médicament (ANSM) has published the results of the call for tenders for the supply and distribution of cannabis-based drugs for experimentation. RESULTS OF THE CALL FOR PROJECTS DelleD had applied and was one of the few French companies to have responded to this call ...
Lire La Suite >

A French pioneer in therapeutic cannabis-based medicines, LaFleur created by DelleD proposes the experimentation of a medical device of cannabis flower by vaporization in order to obtain a marketing authorization from the ANSM (National Agency for the Safety of Medicines and Health Products). DELLED PARTNERS WITH RYAH TO EXPERIMENT A ...
Lire La Suite >

Thanks to the private investor financing signed on July 31, 2020, DelleD can now accelerate its LaFleur project and develop its new oncology treatment based on cannabis assets. DELLED IS PURSUING ITS FLOWER RESEARCH PROGRAM AND SETTING UP IN ANGERS, FRANCE. Large-scale, long-term financing provides DelleD with the opportunity to ...
Lire La Suite >

In collaboration with DelleD SAS ("DelleD" or the "Company"), a French public laboratory received the first stocks of cannabis a few days ago. They will be used to carry out work on the processing for the elaboration of the first batches of cannabis intended for medical use and produced on ...
Lire La Suite >